| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |